Studying Periostin as a Diagnostic Marker in Sera of Iraqi Patients Hypothyroidism

Article Sidebar

pdf
Published: Apr 20, 2024
DOI: https://doi.org/10.30526/37.2.3350

Main Article Content

Duha Khalil Ibrahim
Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq
https://orcid.org/0009-0003-1109-0435
Layla Othman Farhan
Department of Chemistry, College of Science for Women, University of Baghdad, Baghdad, Iraq
https://orcid.org/0000-0003-1886-7780

Abstract

Hypothyroidism is one of the most common thyroid diseases in adults. Hypothyroidism is a condition that results from a deficiency of thyroid hormone and can range from being asymptomatic to life-threatening. A decrease in thyroid hormone production in the thyroid gland, a shortage of pituitary thyroid stimulating hormone, or a hypothalamic Thyrotropin-releasing hormone deficiency can cause hypothyroidism. Thyrotropin-releasing hormone deficiency Periostin is classified as both an extracellular matrix protein and a matricellular protein that belongs to the fasciclin family. As a matricellular protein, Postn plays a crucial role in the growth and maintenance of tissues and organs. Due to the limited research on the effects of Postn on the thyroid gland, the aim of this study is to investigate the relationship between Postn and hypothyroidism. The 120 samples were divided into two groups: 80 patients with hypothyroidism and 40 healthy people. Postn levels significantly increased in the hypothyroidism group compared to the control group (p ˂ 0.001). The results indicate that Postn can be a sensitive and accurate marker for diagnosing hypothyroidism in Iraqi patients.

Article Details

How to Cite
Studying Periostin as a Diagnostic Marker in Sera of Iraqi Patients Hypothyroidism. (2024). Ibn AL-Haitham Journal For Pure and Applied Sciences, 37(2), 339-347. https://doi.org/10.30526/37.2.3350
Issue
Vol. 37 No. 2 (2024)
Section
Chemistry
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

licenseTerms

How to Cite

Studying Periostin as a Diagnostic Marker in Sera of Iraqi Patients Hypothyroidism. (2024). Ibn AL-Haitham Journal For Pure and Applied Sciences, 37(2), 339-347. https://doi.org/10.30526/37.2.3350
Crossref
Scopus
Google Scholar
Europe PMC

Publication Dates

References

Theocharis, A.D.; Manou, D.; Karamanos, N.K. The extracellular matrix as a multitasking player in disease. FEBS J. 2019, 286(15), 2830–2869.

https://doi: https://doi.org/10.1111/febs.14818.

Bornstein, P.; Sage, E.H. Matricellular proteins: Extracellular modulators of cell function. Curr. Opin. Cell Biol., 2002, 14(5), 608–616.

https://doi.org/10.1016/S0955-0674(02)00361-7.

Conway, S.J.; Izuhara, K.; Kudo, Y.; Litvin, J.; Markwald, R.; Ouyang, G.; Arron, J.R.; Holweg, C.T.J.; Kudo, A. The role of periostin in tissue remodeling across health and disease. Cell. Mol. Life Sci., 2014, 71(7),1279–1288. https://doi: 10.3390/nu11071652.

Duan, X.; Attur, M.; Cai, L.; Han, T.; Zhang, W.; Samuels, J.; Brophy, R.H.; Abramson, S.B.; Rai, M.F. Periostin-null mice are protected from post-traumatic and age-related osteoarthrtis. Osteoarthr. Cartil., 2021, 29, S99–S100.

https://doi: 10.15537/smj.2022.43.11.20220558.

Kudo, A.A. Springer. Periostin 2019, 1st ed., pp. 43–47.https://doi.org/10.1111/ahe.12801.

Farhan, L.O.; Taha, E.M.; Farhan, A.M. A case control study to determine macrophage migration inhibitor, and N-telopeptides of type I bone collagen levels in the sera of osteoporosis patients. Baghdad Sci. J., 2022, 19(4),0848.

https://doi.org/10.1016/j.regpep.2008.08.003.

Massy, E.; Rousseau, J.C.; Gueye, M.; Bonnelye, E.; Brevet, M.; Chambard, L.; Duruisseaux, M.; Borel, O.; Roger, C.; Guelminger, R. Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma. J. Bone Oncol., 2021, 29, 100364. https://doi: doi.org/10.18001/TRS.9.1.202.

Liu, A.Y.; Zheng, H.; Ouyang, G. Periostin, a multifunctional matricellular protein in inflammatory and tumor microenvironments. Matrix Biol., 2014, 37, 150–156.

https//:dx.doi.org/10.21123/bsj.2023.7103.

Farhan, L.O.; Mehdi, W.A.; Taha, E.M.; Farhan, A.M.; Mehde, A.A.; Özacar, M. Various type immobilizations of isocitrate dehydrogenases enzyme on hyaluronic acid modified magnetic nanoparticles as stable biocatalysts. Int. J. Biol. Macromol., 2021, 182, 217–227. https://doi: 10.1007/s12013-020-00958-7.

Nishizawa, H.; Matsubara, A.; Nakagawa, T.; Ohta, N.; Izuhara, K.; Shirasaki, T.; Abe, T.; Takeda, I.; Shinkawa, H. The role of periostin in eosinophilic otitis media. Acta Otolaryngol., 2012, 132(8), 838–844.

https://doi.org/10.1016/j.atherosclerosis.2017.06.811.

Ishida, A.; Ohta, N.; Suzuki, Y.; Kakehata, S.; Okubo, K.; Ikeda, H.; Shiraishi, H.; Izuhara, K. Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol. Int., 2012, 61(4),589–595. https://doi:10.1111/bph.13502.

Izuhara, K.; Arima, K.; Ohta, S.; Suzuki, S.; Inamitsu, M. Yamamoto Ki. Periostin allergic inflammation. Allergol. Int. 2014, 63(2), 143–151.

https://doi: 10. 1016/j.peptides.2017.12.006.

Horiuchi, K.; Amizuka, N.; Takeshita, S.; Takamatsu, H.; Katsuura, M.; Ozawa, H.; Toyama, Y.; Bonewald, L.F.; Kudo, A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β. J. bone Miner. Res., 1999, 14(7),1239–1249. https://doi: 10.7759/cureus.37972.

Takeshita, S.; Kikuno, R.; Tezuka, K.; Amann, E. Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I. Biochem. J., 1993, 294 ( Pt 1)(Pt 1), 271–278. https://doi: 10.1093/intimm/dxac060.

Kudo, A. Periostin in fibrillogenesis for tissue regeneration: Periostin actions inside and outside the cell. Cell. Mol. life Sci., 2011, 68(19),3201–3207.

https://doi.org/10.1007%2Fs00018-011-0784-5.

Norris, R.A.; Moreno-Rodriguez, R.; Hoffman, S.; Markwald, R.R. The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. J. Cell Commun. Signal., 2009,3(3-4), 275–286.

https://doi.org/10.1016/B978-0-12-820649-2.00152-2.

Shimazaki, M.; Nakamura, K.; Kii, I.; Kashima, T.; Amizuka, N.; Li, M.; Saito, M.; Fukuda, K.; Nishiyama, T.; Kitajima, S. Periostin is essential for cardiac healing after acute myocardial infarction. J. Exp. Med., 2008, 205(2),295–303.

https://doi:10.29252/ijwph.14.4.409.

Takayama, I.; Kudo, A. Periostin in dental science. Jpn. Dent. Sci. Rev., 2012, 48, 92–98. https://doi/epdf/10.3316/informit.154784110868319.

Preda, S.A.; Comanescu, M.C.; Albulescu, D.M.; Dascălu, I.T.; Camen, A.; Cumpătă, C.N.; Perlea, P.; Bugălă, N.M.; Stoica, E.L.; Gheorghiță, L.M. Correlations between periodontal indices and osteoporosis. Exp. Ther. Med., 2022, 23(4), 1–7.

https://doi.org/10.3389/fpubh.2020.00108.

Iacovides, S.; Maloney, S.K.; Bhana, S.; Angamia, Z.; Meiring, R.M. Could the ketogenic diet induce a shift in thyroid function and support a metabolic advantage in healthy participants? A pilot randomized-controlled-crossover trial. PLOS One, 2022, 17(6), e0269440. https://doi: 10.1161/CIRCULATIONAHA.109.887521.

Teixeira, P.D.D.; Santos, P.B.D; Pazos-Moura, C.C. The role of thyroid hormone in metabolism and metabolic syndrome. Ther. Adv. Endocrinol. Metab., 2020, 11, 2042018820917869. https://doi.org/10.1186/s12889-021-10429-0.

Liu, H.; Peng, D. Update on dyslipidemia in hypothyroidism: The mechanism of dyslipidemia in hypothyroidism. Endocr. Connect., 2022, 11(2), e210002.

https://doi: 10.3390/ijerph18042142.

Mehde, A.A.; Yusof, F.; Mehdi, W.A.; Raus, R.A.; Farhan, L.O.; Zainulabdeen, J.A.; Abidin, Z.A.Z.; Ghazali, H.; Abd Rahman, A. Serum E3 SUMO-protein ligase NSE2 level and peroxynitrite related to oxidative stress in nephrolithiasis patients. Asian Pac. J. Trop. Biomed., 2017, 7(3),249–252. https://doi:10.4062/biomolther.2021.122.

Xu, Y.; Zhao, Y.; Xu, X.; Yan, Q.; Yang, L. Serum lipid profile in relation to free thyroxine and the effect of levothyroxine treatment on lipids in patients with isolated hypothyroxinemia during pregnancy: A single-center retrospective study. Lipids Health Dis., 2022, 21(1),1–10. https://doi: 10.1515/cclm-2023-0360.

Ejaz, M.; Kumar, P.; Thakur, M.; Bachani, P.; Naz, S.; Lal, K.; Shahid, W.; Shahid, S.; Jahangir, M.; Rizwan, A. Comparison of lipid profile in patients with and without subclinical hypothyroidism. Cureus 2021,13(8):e17301.

http://www.biomedcentral.com/1471-2261/14/177

Khaleel, F.M.; Oda, N.N.; Abed, B.A. Disturbance of arginase activity and nitric oxide levels in Iraqi type 2 diabetes mellitus. Baghdad Sci. J., 2018, 15(2), 189–191.

https://doi: 10.4103/2230-8210.91191.

Xu, D.; Zhong, H. Correlation between hypothyroidism during pregnancy and glucose and lipid metabolism in pregnant women and its influence on pregnancy outcome and fetal growth and development. Front. Surg., 2022, 9. https://doi: 10.18632/oncotarget.5792.

Walczak, K.; Sieminska, L. Obesity and Thyroid Axis. Int. J. Environ. Res. Public Health 2021, 18, 9434. https://doi.org/10.1038/s41598-019-48120-5.

Dorafshan, S.; Razmi, M.; Safaei, S.; Gentilin, E.; Madjd, Z.; Ghods, R. Periostin: Biology and function in cancer. Cancer Cell Int.,2022,22(315),1–28.

https://doi:10.3390/diagnostics13050929.

Abed, B.; Hamid, S. Evaluation of lipocalin-2 and vaspin levels in Iraqi women with type 2 diabetes mellitus. Iraqi J Sci., 2022,63(11),4650–4658.https://doi: 10.1186/s12944-018-0691-y.